The Modern Financial Terminal

Subscribe for $2

Trusted by leading companies and financial institutions

Fresenius Medical Care Stock FME.DE

Currency:

Price

40.54 EUR

Today +/-

-0.83 EUR

Today %

-2.02 %

Ticker
FME.DE

ISIN
DE0005785802

Fresenius Medical Care stock price

Weekly

Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Fresenius Medical Care stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Fresenius Medical Care stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Fresenius Medical Care stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Fresenius Medical Care's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Fresenius Medical Care Stock Price History

Date	Fresenius Medical Care Price
2/18/2026	40.54 EUR
2/17/2026	41.37 EUR
2/16/2026	40.94 EUR
2/13/2026	41.01 EUR
2/12/2026	39.92 EUR
2/11/2026	40.13 EUR
2/10/2026	40.21 EUR
2/9/2026	39.72 EUR
2/6/2026	40.57 EUR
2/5/2026	40.66 EUR
2/4/2026	40.16 EUR
2/3/2026	39.00 EUR
2/2/2026	38.11 EUR
1/30/2026	37.61 EUR
1/29/2026	37.42 EUR
1/28/2026	37.27 EUR
1/27/2026	37.13 EUR
1/26/2026	37.34 EUR
1/23/2026	37.18 EUR
1/22/2026	37.38 EUR
1/21/2026	36.11 EUR
1/20/2026	35.99 EUR

Fresenius Medical Care Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Revenue

EBIT

Net Income

Details

Fresenius Medical Care Income Statement, Balance Sheet, Cash Flow Statement

REVENUE (B EUR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B EUR)

NET INCOME (B EUR)

NET INCOME GROWTH (%)

DIVIDEND (EUR)DIV. (EUR)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

DOCUMENTS

1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e	2028e	2029e	2030e	2031e
0.69	1.2	2.88	3.13	3.61	4.56	5.43	5.39	4.89	5.01	5.45	6.77	7.13	7.23	8.07	9.09	9.19	10.96	11.22	12.14	15.45	16.57	17.78	16.55	17.48	17.86	17.62	19.4	19.45	19.34	19.75	20.18	21.01	22.68	22.7	23.79	24.26
–	72.77	140.53	8.43	15.38	26.39	19.04	-0.66	-9.29	2.49	8.72	24.22	5.24	1.47	11.55	12.72	1.11	19.22	2.34	8.28	27.26	7.21	7.33	-6.96	5.62	2.19	-1.35	10.10	0.28	-0.61	2.15	2.15	4.13	7.95	0.11	4.76	1.98
42.65	41.37	40.67	37.10	36.86	34.91	33.73	32.57	33.08	33.49	34.44	33.86	34.62	34.32	34.11	34.34	35.38	34.65	33.71	32.85	33.50	33.89	33.84	31.15	30.87	31.00	27.09	25.22	25.32	24.60	24.08	23.57	22.64	20.97	20.95	20.00	19.61
0.3	0.5	1.17	1.16	1.33	1.59	1.83	1.76	1.62	1.68	1.88	2.29	2.47	2.48	2.75	3.12	3.25	3.8	3.78	3.99	5.18	5.62	6.02	5.15	5.4	5.54	4.77	4.89	4.93	4.76	0	0	0	0	0	0	0
0.05	0.07	0.08	0.01	-0.23	0.23	0.07	0.31	0.29	0.32	0.37	0.43	0.53	0.56	0.64	0.74	0.78	0.92	0.81	0.78	0.95	1.14	1.28	1.98	1.2	1.16	0.97	0.67	0.5	0.54	1.16	1.22	1.38	1.64	1.7	1.87	1.95
–	29.63	14.29	-83.75	-1,892.31	-198.28	-69.87	343.48	-4.90	10.65	13.35	16.99	24.36	4.90	14.18	16.67	4.58	18.56	-11.85	-3.70	22.15	19.81	11.90	54.89	-39.48	-2.92	-16.75	-30.55	-26.00	7.83	116.01	4.83	13.57	18.68	3.42	10.32	4.12
-	-	-	-	-	-	-	-	-	-	0.37	0.41	0.47	0.54	0.58	0.61	0.65	0.69	0.75	0.77	0.78	0.80	0.96	1.06	1.17	1.20	1.34	1.35	1.12	1.19	1.44	2.53	2.94	3.42	3.55	3.93	4.08
–	–	–	–	–	–	–	–	–	–	–	10.81	14.63	14.89	7.41	5.17	6.56	6.15	8.70	2.67	1.30	2.56	20.00	10.42	10.38	2.56	11.67	0.75	-17.04	6.25	21.01	75.69	16.21	16.33	3.80	10.70	3.82
106	133	230	237	237	268	289	289	289	290	293	296	297	298	298	302	305	307	305	302.87	305.27	306.7	307.64	307.28	302.69	294.06	292.94	293.25	293.41	293.41	0	0	0	0	0	0	0
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Keystats

ⓘ

Revenue and Growth

The Fresenius Medical Care Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Fresenius Medical Care is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

ASSETS

CASH BALANCE (B EUR)

RECEIVABLES (B EUR)

OTHER RECEIVABLES (M EUR)OTHER REC. (M EUR)

INVENTORIES (B EUR)

OTHER CURRENT ASSETS (M EUR)OTHER CURRENT LIAB. (M EUR)

CURRENT ASSETS (B EUR)

TANGIBLE ASSETS (B EUR)

LONG-TERM INVESTMENTS (B EUR)LONG-T. INVEST. (B EUR)

LONG-TERM RECEIVABLES (M EUR)LONG-T. REC. (M EUR)

INTANGIBLE ASSETS (B EUR)INTANGIBLE ASSETS (B EUR)

GOODWILL (B EUR)

OTHER NON-CURRENT ASSETS (B EUR)OTHER NON-CURRENT ASSETS (B EUR)

NON-CURRENT ASSETS (B EUR)

TOTAL ASSETS (B EUR)

LIABILITIES

COMMON STOCK (M EUR)

ADDITIONAL PAID-IN CAPITAL (B EUR)

RETAINED EARNINGS (B EUR)

OTHER EQUITY (M EUR)OTHER EQUITY (M EUR)

UNREALIZED GAINS/LOSSES (M EUR)UNREAL. GAINS/LOSSES (M EUR)

EQUITY (B EUR)

LIABILITIES (M EUR)

PROVISIONS (B EUR)

OTHER SHORT-TERM LIABILITIES (B EUR)OTHER SHORT-TERM LIAB. (B EUR)

SHORT-TERM DEBTS (B EUR)SHORT-TERM DEBTS (B EUR)

SHORT-TERM PORTION OF LONG-TERM DEBTS (B EUR)LONG-TERM DEBT PORTION (B EUR)

SHORT-TERM RECEIVABLES (B EUR)SHORT-TERM REC. (B EUR)

LONG-TERM LIABILITIES (B EUR)LONG-T. LIAB. (B EUR)

DEFERRED TAXES (M EUR)

OTHER LIABILITIES (B EUR)OTHER LIAB. (B EUR)

LONG-TERM LIABILITIES (B EUR)LONG-T. LIABILITIES (B EUR)

DEBT (B EUR)

TOTAL CAPITAL (B EUR)

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

0.05	0.03	0.03	0.04	0.07	0.07	0.06	0.04	0.04	0.07	0.12	0.17	0.16	0.21	0.39	0.35	0.52	0.5	0.66	0.75	0.96	0.99	2.27	1.14	1.24	1.62	1.46	1.56	1.49
0.56	0.74	0.54	0.71	0.85	1.04	0.91	1.02	1.12	1.27	1.51	1.45	1.69	1.78	2.01	2.25	2.39	2.32	2.64	3.02	3.34	3.39	3.34	3.42	3.15	3.41	3.57	3.47	3.37
0	0	0	0	0	0	0	0	0	0	0	0	0	0	246	313	230	349	421.47	598.24	587	306.83	427.86	547.92	426.25	360.17	457.33	575.43	532.47
0.21	0.23	0.25	0.3	0.34	0.39	0.36	0.35	0.33	0.36	0.4	0.43	0.51	0.57	0.61	0.75	0.79	0.8	0.92	1.23	1.34	1.29	1.47	1.66	1.9	2.04	2.3	2.18	2.07
203	218	390	485	421	505	409	344	317	373	558	337	495	562	398	484	472	362	648.89	569.22	656.03	393.8	349.38	391.56	557.48	541.98	414.02	918.56	465.7
1.03	1.22	1.22	1.53	1.68	2	1.74	1.75	1.8	2.08	2.59	2.38	2.85	3.12	3.65	4.15	4.4	4.32	5.29	6.17	6.88	6.37	7.85	7.17	7.28	7.97	8.2	8.7	7.92
0.49	0.67	0.54	0.64	0.78	0.94	0.87	0.87	0.87	1.03	1.31	1.4	1.61	1.68	1.89	2.03	2.23	2.24	2.71	3.15	3.58	3.49	3.84	8.52	8.19	8.55	8.34	7.45	7.26
0.02	0.03	0.02	0.01	0	0	0	0	0	0	0	0	0	0	0.19	0.54	0.48	0.48	0.51	0.55	0.6	0.65	0.65	0.7	0.76	0.79	0.77	1.25	1.42
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	307.4	293.46	0	0
2.46	3.09	2.97	3.42	0.59	0.65	0.52	0.46	0.44	0.5	0.5	0.48	0.62	0.61	0.53	0.54	0.55	0.55	0.72	0.76	0.8	0.68	0.68	1.43	1.38	1.46	1.52	1.36	1.37
0	0	0	0	3.09	3.49	3.04	2.61	2.54	2.92	5.22	4.93	5.25	5.21	6.09	7.1	8.65	8.45	10.77	11.96	12.96	12.1	12.21	14.02	12.96	14.36	15.79	14.65	15.17
0.07	0.06	0.1	0.12	0.2	0.24	0.28	0.27	0.21	0.22	0.27	0.46	0.43	0.4	0.47	0.71	0.54	0.66	0.85	0.66	0.68	0.73	1.02	1.11	1.13	1.24	1.13	0.51	0.43
3.04	3.86	3.63	4.18	4.67	5.32	4.72	4.21	4.07	4.67	7.3	7.27	7.91	7.91	9.17	10.91	12.44	12.38	15.56	17.07	18.62	17.65	18.4	25.77	24.41	26.71	27.84	25.23	25.64
4.06	5.08	4.85	5.71	6.35	7.32	6.46	5.96	5.87	6.74	9.88	9.65	10.76	11.02	12.82	15.06	16.84	16.7	20.85	23.25	25.5	24.03	26.24	32.93	31.69	34.67	36.05	33.93	33.57

197	234	220	255	312	336	285	237	221	257	232	297	298	300	302	304	307	309	311.1	312.86	307.22	308.11	307.88	304.44	292.88	293	293.41	293.41	293.41
1.51	1.91	1.79	2.08	2.8	3.07	2.61	2.18	2.03	2.4	2.43	3.56	3.61	3.68	3.77	3.86	3.94	4.04	4.13	4.22	3.96	3.97	3.87	3.61	2.87	2.89	3.37	3.38	3.35
0.02	0.1	0.07	-0.22	-0.06	-0.07	0.15	0.3	0.49	0.82	1.03	1.5	1.89	2.36	2.74	3.24	3.9	4.41	4.83	5.37	6.09	7.14	8.83	9.45	10.25	10.83	10.71	10.92	11.27
-7	-17	-65	-134	-205	-403	-365	-139	-51	-121	-4	-1,521	-1,455	-1,545	-1,257	-1,224	-1,317	-1,787	-1,298.37	-652.22	-324.56	-1,485.58	-1,203.75	-1,038.55	-2,205.34	-1,311.64	-388.47	-975.17	-328.55
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.72	2.23	2.01	1.99	2.84	2.94	2.68	2.58	2.68	3.36	3.69	3.84	4.34	4.79	5.55	6.18	6.83	6.98	7.97	9.25	10.03	9.93	11.81	12.33	11.22	12.7	13.99	13.62	14.58
167	225	207	281	298	313	271	244	226	261	419	361	435	444	406	504	565	393	472.11	576.68	575.56	590.49	641.27	716.53	731.99	736.07	813.26	762.07	904.28
0.39	0.41	0.38	0.8	0.42	0.71	0.63	0.55	0.55	0.71	0.91	0.92	0.98	0.98	0.38	0.41	0.45	0.48	1.18	1.96	2.28	2.06	2.06	1.96	2.12	2.23	2.18	1.17	1.19
0.03	0.03	0.06	0.11	0.15	0.22	0.19	0.16	0.17	0.11	0.1	0.1	0.06	0.08	0.98	1.11	1.13	1.28	0.92	0.78	1.03	0.89	0.93	1.07	1.62	1.71	1.44	2.62	2.35
0.1	0.14	0.14	0.42	0.44	0.12	0.13	0.1	0.31	0.14	0.25	0.15	0.49	0.23	0.98	0.1	0.09	0.12	0.12	0.12	0.58	0.77	1.39	1.17	0.08	1.26	0.67	0.46	0
0.02	0.02	0.04	0.15	0.18	0.19	0.02	0.07	0.17	0.11	0.12	0.52	0.33	0.11	0.2	1.23	0.25	0.43	0.34	0.71	0.84	0.99	1.24	2.09	1.62	1.33	1.37	1.1	1.22
0.7	0.83	0.83	1.76	1.48	1.55	1.23	1.12	1.43	1.33	1.8	2.05	2.3	1.84	2.94	3.35	2.48	2.71	3.02	4.14	5.3	5.3	6.27	7.01	6.16	7.26	6.47	6.11	5.66
1.15	1.5	1.77	1.61	1.71	2.43	2.13	1.87	1.35	1.6	3.85	3.17	3.28	3.5	3.19	4.21	5.89	5.58	7.43	7.21	6.83	5.79	5.05	10.52	10.68	10.73	11.18	10.49	9.76
141	134	162	167	187	160	161	199	208	254	287	285	358	351	429	540	608	578	708.34	594.11	661.92	467.54	626.52	739.7	785.89	868.45	936.48	750.29	708.89
0.34	0.4	0.06	0.17	0.11	0.22	0.24	0.18	0.2	0.19	0.2	0.24	0.37	0.39	0.52	0.55	0.62	0.85	1.3	1.49	1.66	1.63	1.4	1.44	1.73	1.53	1.73	1.75	1.67
1.63	2.03	1.99	1.95	2	2.81	2.53	2.25	1.75	2.04	4.34	3.69	4.01	4.25	4.14	5.29	7.12	7.01	9.44	9.3	9.15	7.9	7.07	12.7	13.2	13.13	13.84	12.99	12.14
2.33	2.85	2.82	3.7	3.48	4.36	3.76	3.37	3.18	3.37	6.14	5.74	6.31	6.09	7.08	8.64	9.6	9.71	12.46	13.44	14.45	13.2	13.34	19.71	19.36	20.39	20.3	19.1	17.8
4.05	5.08	4.83	5.69	6.32	7.3	6.44	5.95	5.86	6.73	9.83	9.57	10.65	10.88	12.63	14.82	16.43	16.69	20.43	22.7	24.48	23.13	25.15	32.04	30.57	33.09	34.29	32.72	32.37

Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Fresenius Medical Care provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Fresenius Medical Care's financial health and stability.

Assets

Fresenius Medical Care's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Fresenius Medical Care must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Fresenius Medical Care after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Fresenius Medical Care's financial standing, aiding in investment evaluations and risk assessments.

NET INCOME (B EUR)

DEPRECIATION AND AMORTIZATION B EURDEPRECIATION (B EUR)

DEFERRED TAXES (M EUR)

CHANGES IN WORKING CAPITAL (M EUR)CHANGES IN WORKING CAPITAL (M EUR)

NON-CASH ITEM (M EUR)

PAID INTEREST (M EUR)

PAID TAXES (M EUR)

Net Cash Flow from Operating Activities (B EUR)NET CASH FLOW FROM OPERATING ACTIVITIES (B EUR)

CAPITAL EXPENDITURES (M EUR)

CASH FLOW FROM INVESTING ACTIVITIES (M EUR)CASH FLOW FROM INVESTING ACTIVITIES (M EUR)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (M EUR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M EUR)

INTEREST INCOME AND EXPENSES (M EUR)

NET DEBT CHANGE (B EUR)NET DEBT CHANGE (B EUR)

Net change in equity (M EUR)NET CHANGE IN EQUITY (M EUR)

CASH FLOW FROM FINANCING ACTIVITIES (B EUR)CASH FLOW FROM FINANCING ACTIVITIES (B EUR)

OTHER ITEMS OF FINANCING CASH FLOWS (M EUR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M EUR)

TOTAL DIVIDENDS PAID (M EUR)

NET CHANGE IN CASH FLOW (B EUR)

FREE CASH FLOW (M EUR)

SHARE-BASED COMPENSATION (M EUR)

1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.05	0.07	0.08	0.02	-0.23	0.23	0.07	0.31	0.29	0.32	0.37	0.43	0.53	0.56	0.69	0.81	0.85	1.03	0.92	0.94	1.21	1.42	1.55	2.23	1.44	1.44	1.22	0.89	0.73
0.03	0.08	0.24	0.25	0.27	0.32	0.36	0.22	0.19	0.19	0.2	0.25	0.27	0.28	0.33	0.38	0.4	0.47	0.49	0.53	0.65	0.7	0.74	0.72	1.59	1.79	1.62	1.84	1.75
-2	-3	11	21	-84	83	-51	62	80	27	-3	8	12	103	18	6	106	55	20	87	-36	0	-203	89	64	111	67	-41	-122
-29	-58	-114	-148	294	-210	91	-23	100	126	-36	55	12	-303	-102	-179	-275	135	116	-229	-45	-162	231	-153	-833	685	-652	-650	64
0	0	-1	100	86	4	2	14	1	2	10	-14	54	48	24	16	-49	-104	-15	25	-9	-27	-126	-824	304	215	232	126	201
0	33	130	185	202	241	245	220	184	162	145	301	297	242	238	199	186	272	282	286	342	349	339	311	470	379	341	350	394
0	5	78	-1	26	48	70	134	125	160	306	337	254	233	305	392	327	430	408	519	493	541	674	358	387	301	345	334	410
0.05	0.09	0.22	0.24	0.33	0.42	0.47	0.58	0.67	0.67	0.54	0.72	0.88	0.69	0.96	1.03	1.04	1.59	1.53	1.35	1.77	1.93	2.19	2.06	2.57	4.23	2.49	2.17	2.63
-71	-98	-202	-141	-150	-247	-307	-253	-257	-224	-253	-372	-424	-468	-412	-395	-429	-525	-572	-719	-888	-942	-970	-1,142	-1,162	-1,085	-886	-770	-710
-46	69	-577	-250	-239	-522	-522	-298	-326	-293	-340	-3,378	-567	-604	-500	-847	-1,661	-1,715	-907	-1,979	-901	-1,246	-991	-245	-3,285	-1,334	-1,196	-734	-544
25	167	-375	-108	-88	-275	-215	-44	-68	-69	-86	-3,006	-143	-136	-88	-452	-1,231	-1,189	-335	-1,259	-13	-303	-20	897	-2,123	-249	-309	35	166
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.02	-0.68	0.18	-0.51	-0.01	-0.08	-0.31	0.19	-0.01	-0.41	0.06	2.4	0.01	0.21	-0.01	-0.08	0.77	0.87	-0.15	0.94	-0.3	-0.21	-0.31	0.16	0.32	-1.27	-0.36	-1.12	-1.19
0	335	153	0	1	605	7	-398	1	2	64	43	28	29	50	83	67	95	-274	80	85	47	-10	10	-583	-353	6	20	0
-0.01	-0.11	0.33	0.01	-0.07	0.17	0.05	-0.28	-0.37	-0.36	-0.18	2.69	-0.25	-0.09	-0.41	-0.02	0.59	0.34	-0.62	0.63	-0.91	-0.52	-0.8	-0.68	-0.47	-2.66	-1.02	-1.62	-1.86
-22	234	0	568	-16	-298	424	5	-262	143	-193	369	-152	-173	-272	159	-55	-412	29	-163	-457	-110	-185	-528	153	-693	-279	-123	-340
0	0	0	-43	-45	-55	-73	-81	-95	-98	-110	-122	-138	-160	-172	-182	-196	-209	-230	-232	-236	-244	-293	-324	-354	-351	-392	-395	-328
0	0.04	-0.02	-0.01	0	0.03	-0	0	-0.01	0.01	0.02	0.06	0.05	-0.01	0.05	0.18	-0.04	0.17	-0.03	0.03	-0.02	0.2	0.27	1.17	-1.14	0.07	0.4	-0.21	0.15
-18.4	-12.2	14.8	97.5	179.1	177.1	166.5	329.6	409.6	442	286.1	351	452.3	221.9	548.5	636.9	606	1,061.5	960	635.1	878.37	989.28	1,220.98	919.53	1,404.19	3,147.92	1,602.78	1,397.04	1,917.84
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Fresenius Medical Care stock margins

The Fresenius Medical Care margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fresenius Medical Care. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fresenius Medical Care.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Gross margin

EBIT margin

Profit margin

Details

Fresenius Medical Care Stock Sales Revenue, EBIT, Earnings per Share

The Fresenius Medical Care earnings per share therefore indicates how much revenue Fresenius Medical Care has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Sales per Share

EBIT per share

Earnings per Share

Details

Fresenius Medical Care business model

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease. Fresenius Medical Care is one of the most popular companies on Eulerpool.com.

Fresenius Medical Care SWOT Analysis

Helpful

Harmful

Internal

Strengths

Fresenius Medical Care AG is a global leader in the field of dialysis and renal care, with a strong market presence in over 120 countries. The company benefits from its extensive network of clinics and partnerships, allowing it to provide comprehensive and high-quality services to patients worldwide.

The company's strong financial performance and profitability are key strengths, enabling it to invest in research and development, expand its operations, and attract top talent. Fresenius Medical Care AG's strong brand reputation and recognized expertise further contribute to its competitive advantage in the market.

Weaknesses

Despite its global presence, Fresenius Medical Care AG may face challenges in certain regions due to regulatory and reimbursement constraints. Adapting to diverse regulatory environments and addressing pricing pressures can potentially hinder the company's growth and profitability.

As a specialized healthcare provider, Fresenius Medical Care AG's success heavily relies on the availability of skilled healthcare professionals, efficient supply chain management, and technological advancements. Any weaknesses in these areas may impact the company's ability to deliver consistent and high-quality care to its patients.

External

Opportunities

The increasing incidence of chronic kidney diseases and the rising aging population present significant growth opportunities for Fresenius Medical Care AG. As the demand for renal care services continues to grow, the company can expand its market share by offering innovative treatment options and enhancing patient experience.

Strategic collaborations and partnerships with healthcare providers, research institutions, and technology companies can also open up new avenues for Fresenius Medical Care AG to develop and deliver advanced dialysis solutions. Additionally, entering emerging markets with underserved renal care needs can fuel the company's expansion and revenue growth.

Threats

Fresenius Medical Care AG operates in a highly competitive industry, facing competition from both established players and emerging entrants. Pricing pressures and the potential loss of key contracts can pose threats to the company's market position and profitability.

Rapid advancements in medical technology and the potential disruption caused by new treatment methods or alternative therapies also present threats to the traditional dialysis market, requiring Fresenius Medical Care AG to adapt and innovate to stay ahead.

Fresenius Medical Care Eulerpool Fair Value

Loading chart...

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Fresenius Medical Care historical P/E ratio, EBIT multiple, and P/S ratio

Fresenius Medical Care shares outstanding

The number of shares was Fresenius Medical Care in 2025 — This indicates how many shares 293.414 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Number of stocks

Details

Fresenius Medical Care stock splits

In Fresenius Medical Care's history, there have been no stock splits.

Fresenius Medical Care dividend history and estimates

In 2025, Fresenius Medical Care paid a dividend amounting to 1.44 EUR. Dividend means that Fresenius Medical Care distributes a portion of its profits to its owners.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Dividend

Dividend (Estimate)

Details

Fresenius Medical Care dividend payout ratio

In 2025, Fresenius Medical Care had a payout ratio of 60.4%. The payout ratio indicates the percentage of the company's profits that Fresenius Medical Care distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Loading chart...

Payout ratio

Details

Unfortunately, there are currently no price targets and forecasts available for Fresenius Medical Care.

Fresenius Medical Care Earnings Calls

Fresenius Medical Care Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
7/31/2023	0 EUR	0 EUR	2023 Q2
5/2/2023	0 EUR	0 EUR	2023 Q1
2/20/2023	0.69 EUR	5.28 B EUR	2022 Q4
10/30/2022	0.68 EUR	5.12 B EUR	2022 Q3
7/28/2022	0.83 EUR	4.84 B EUR	2022 Q2
5/4/2022	0.7 EUR	4.54 B EUR	2022 Q1
2/22/2022	0.88 EUR	4.68 B EUR	2021 Q4
11/2/2021	0.92 EUR	4.54 B EUR	2021 Q3
7/30/2021	0.76 EUR	4.38 B EUR	2021 Q2
5/6/2021	0.8 EUR	4.29 B EUR	2021 Q1
2/23/2021	1.21 EUR	4.52 B EUR	2020 Q4
10/29/2020	1.16 EUR	4.46 B EUR	2020 Q3
7/30/2020	1.09 EUR	4.53 B EUR	2020 Q2
5/6/2020	0.87 EUR	4.49 B EUR	2020 Q1
2/19/2020	1.32 EUR	4.65 B EUR	2019 Q4
10/29/2019	1.09 EUR	4.48 B EUR	2019 Q3
7/30/2019	0.97 EUR	4.42 B EUR	2019 Q2
5/2/2019	0.93 EUR	4.17 B EUR	2019 Q1
2/20/2019	1.28 EUR	4.3 B EUR	2018 Q4
10/30/2018	1.07 EUR	4.15 B EUR	2018 Q3
7/31/2018	1.05 EUR	4.27 B EUR	2018 Q2
4/22/2018	0.97 EUR	4.29 B EUR	2018 Q1
2/27/2018	1.33 EUR	4.52 B EUR	2017 Q4
11/2/2017	0.96 EUR	4.29 B EUR	2017 Q3
8/1/2017	0.91 EUR	4.59 B EUR	2017 Q2
5/3/2017	0.91 EUR	4.46 B EUR	2017 Q1
2/22/2017	1.12 EUR	4.5 B EUR	2016 Q4
10/27/2016	0.98 EUR	4.26 B EUR	2016 Q3
8/2/2016	0.85 EUR	4.04 B EUR	2016 Q2
5/3/2016	0.7 EUR	3.77 B EUR	2016 Q1
2/24/2016	1.03 EUR	4.1 B EUR	2015 Q4
10/29/2015	0.81 EUR	3.96 B EUR	2015 Q3
7/30/2015	0.76 EUR	3.79 B EUR	2015 Q2
4/29/2015	0.67 EUR	3.66 B EUR	2015 Q1
2/25/2015	0.95 EUR	3.8 B EUR	2014 Q4
11/4/2014	0.73 EUR	3.22 B EUR	2014 Q3
7/31/2014	0.62 EUR	2.88 B EUR	2014 Q2
5/6/2014	0.53 EUR	2.65 B EUR	2014 Q1
2/25/2014	0.74 EUR	2.87 B EUR	2013 Q4
11/5/2013	0.62 EUR	2.66 B EUR	2013 Q3
7/30/2013	0.64 EUR	2.77 B EUR	2013 Q2
4/30/2013	0.61 EUR	2.75 B EUR	2013 Q1
2/26/2013	0.81 EUR	2.79 B EUR	2012 Q4
10/31/2012	0.73 EUR	2.74 B EUR	2012 Q3
8/1/2012	0.75 EUR	2.88 B EUR	2012 Q2
5/3/2012	0.59 EUR	2.5 B EUR	2012 Q1
2/21/2012	0.81 EUR	2.69 B EUR	2011 Q4
11/2/2011	0.68 EUR	2.42 B EUR	2011 Q3
8/2/2011	0.61 EUR	2.27 B EUR	2011 Q2
5/4/2011	0.51 EUR	2.07 B EUR	2011 Q1
2/23/2011	0.66 EUR	2.37 B EUR	2010 Q4
11/2/2010	0.6 EUR	2.23 B EUR	2010 Q3
8/3/2010	0.62 EUR	2.29 B EUR	2010 Q2
5/4/2010	0.55 EUR	2.18 B EUR	2010 Q1
2/24/2010	0.62 EUR	2.25 B EUR	2009 Q4
11/3/2009	0.51 EUR	1.97 B EUR	2009 Q3
8/4/2009	0.52 EUR	1.98 B EUR	2009 Q2
5/20/2009	0.49 EUR	2 B EUR	2009 Q1
2/19/2009	0.57 EUR	2.16 B EUR	2008 Q4
11/4/2008	0.56 EUR	2.1 B EUR	2008 Q3
7/30/2008	0.45 EUR	1.7 B EUR	2008 Q2
4/30/2008	0.41 EUR	1.63 B EUR	2008 Q1
2/20/2008	0.45 EUR	1.75 B EUR	2007 Q4
10/31/2007	0.42 EUR	1.77 B EUR	2007 Q3
8/2/2007	0.43 EUR	1.76 B EUR	2007 Q2
5/2/2007	0.41 EUR	1.69 B EUR	2007 Q1
2/22/2007	0.41 EUR	1.79 B EUR	2006 Q4
10/31/2006	0.39 EUR	1.77 B EUR	2006 Q3
8/3/2006	0.33 EUR	1.71 B EUR	2006 Q2
5/3/2006	0.33 EUR	1.42 B EUR	2006 Q1
2/22/2006	0.36 EUR	1.5 B EUR	2005 Q4
11/3/2005	0.33 EUR	1.42 B EUR	2005 Q3
8/4/2005	0.33 EUR	1.36 B EUR	2005 Q2
5/4/2005	0.29 EUR	1.29 B EUR	2005 Q1

...

Eulerpool ESG Scorecard© for the Fresenius Medical Care stock

Eulerpool World ESG Rating (EESG©)

81/ 100

🌱 Environment

👫 Social

🏛️ Governance

Environment

Scope 1 - Direct Emissions	360,803
Scope 2 - Indirect emissions from purchased energy	450,611
Scope 3 - Indirect emissions within the value chain	2,993,388
Total CO₂ emissions	811,414
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees	70
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Fresenius Medical Care shareholders

%	Name	Stocks	Change	Date
28.55369 %	Fresenius SE & Co KGaA	83,780,382	-10,600,000	3/6/2025
5.20000 %	Pzena Investment Management, LLC	15,257,499	0	1/27/2025
5.01054 %	BlackRock Institutional Trust Company, N.A.	14,701,599	735,279	8/12/2025
4.97569 %	Dodge & Cox	14,599,335	-71,900	7/3/2025
3.01452 %	Artisan Partners Limited Partnership	8,845,012	59,950	4/30/2025
2.98139 %	Harris Associates L.P.	8,747,803	-52,974	4/14/2025
2.40875 %	The Vanguard Group, Inc.	7,067,609	2,557	7/31/2025
2.22382 %	DWS Investment GmbH	6,524,982	22,090	7/31/2025
0.81251 %	Fiduciary Management, Inc.	2,384,000	-113,000	3/31/2025
0.78782 %	BlackRock Advisors (UK) Limited	2,311,575	33,398	7/31/2025
0.71561 %	Deka Investment GmbH	2,099,706	-2,461	7/31/2025
0.70246 %	Norges Bank Investment Management (NBIM)	2,061,107	781,268	12/31/2024
0.69568 %	Geode Capital Management, L.L.C.	2,041,215	457	7/31/2025
0.68644 %	Dimensional Fund Advisors, L.P.	2,014,108	4,897	7/31/2025
0.64933 %	Columbia Threadneedle Investments (US)	1,905,229	-20,401	6/30/2025
0.53154 %	BlackRock Asset Management Deutschland AG	1,559,605	-16,720	7/31/2025
0.52927 %	BDL Capital Management	1,552,949	93,947	6/30/2025
0.52805 %	Baillie Gifford & Co.	1,549,363	-8,196	3/31/2025
0.48137 %	Schroder Investment Management Ltd. (SIM)	1,412,400	-12,666	6/30/2025
0.42459 %	Invesco Advisers, Inc.	1,245,797	92	7/31/2025
0.40730 %	BlackRock Investment Management (UK) Ltd.	1,195,070	-19,084	6/30/2025
0.39027 %	Charles Schwab Investment Management, Inc.	1,145,106	1,365	7/31/2025
0.38822 %	Nuveen LLC	1,139,083	0	6/30/2025
0.38349 %	Amundi Asset Management, SAS	1,125,199	148,952	7/31/2025
0.37778 %	Arga Investment Management, LP	1,108,464	-347,886	6/30/2025
0.31926 %	M&G Investment Management Ltd.	936,756	967	6/30/2025
0.31207 %	California State Teachers Retirement System	915,668	-53,792	6/30/2024
0.30969 %	Lazard Asset Management, L.L.C.	908,668	-27,151	7/31/2025
0.29911 %	Goldman Sachs Asset Management International	877,624	0	6/30/2025
0.22091 %	Eurizon Capital SGR S.p.A.	648,174	-62,222	6/30/2025
0.21583 %	Goldman Sachs Asset Management, L.P.	633,289	0	7/31/2025
0.21570 %	Macquarie Investment Management	632,891	0	5/31/2024
0.18881 %	CPP Investment Board	554,000	282,000	3/31/2024
0.18318 %	Lazard Asset Management Pacific Company	537,481	-51,597	4/30/2025
0.18026 %	State Street Global Advisors (UK) Ltd.	528,900	-1,426	7/31/2025
0.16433 %	Aviva Investors Global Services Limited	482,177	23,132	6/30/2025
0.15991 %	1832 Asset Management L.P.	469,188	459,080	12/31/2024
0.15769 %	Dimensional Fund Advisors, Ltd.	462,687	0	6/30/2025
0.15482 %	State Street Global Advisors (US)	454,264	1,345	7/31/2025
0.15355 %	APG Asset Management N.V.	450,549	5,406	12/31/2024
0.13258 %	Franklin Advisers, Inc.	389,013	-20,030	6/30/2025
0.12490 %	Florida State Board of Administration	366,461	-237,588	3/31/2025
0.12285 %	AQR Capital Management, LLC	360,445	106,623	6/30/2025
0.11998 %	Marathon-London	352,047	-9,331	6/30/2025
0.11835 %	UBS Asset Management (UK) Ltd.	347,269	4,923	7/31/2025
0.11243 %	California Public Employees' Retirement System	329,892	-369,534	6/30/2024
0.10331 %	Allianz Global Investors GmbH	303,114	87,018	6/30/2025
0.10019 %	Oddo BHF Asset Management S.A.S	293,972	0	6/30/2025
0.09646 %	AG2R La Mondiale Gestion d'Actifs SA	283,017	283,017	3/31/2025
0.08976 %	JPMorgan Asset Management U.K. Limited	263,368	0	7/31/2025
0.08930 %	HSBC Global Asset Management (UK) Limited	262,005	88	6/30/2025
0.08218 %	Caisse de Depot et Placement du Quebec	241,132	-101,330	12/31/2024
0.08041 %	Ariel Investments, LLC	235,947	-8,273	6/30/2025
0.08014 %	Legal & General Investment Management Ltd.	235,127	544	7/31/2025
0.07614 %	DWS Investments UK Limited	223,412	4,239	7/31/2025
0.07570 %	Brandes Investment Partners, L.P.	222,116	-30	6/30/2025
0.07253 %	Mediolanum International Funds Limited	212,817	-6,222	3/31/2025
0.07166 %	Wellington Management Company, LLP	210,249	26,984	6/30/2025
0.06831 %	Vanguard Global Advisers LLC	200,426	5,712	6/30/2025
0.06721 %	AXA Investment Managers Paris	197,198	0	6/30/2025
0.06644 %	LBP AM	194,931	73,352	5/31/2025
0.06406 %	BNP Paribas Asset Management Europe SAS	187,948	27,235	6/30/2025
0.06254 %	Oddo BHF Asset Management GmbH	183,500	12,750	6/30/2025
0.06092 %	Northern Trust Global Investments Limited	178,749	34,073	6/30/2025
0.06067 %	Northern Trust Investments, Inc.	178,018	127	7/31/2025
0.05840 %	Candriam Luxembourg S.A.	171,352	-2,577	6/30/2025
0.05370 %	Goldman Sachs Asset Management B.V.	157,553	6,053	4/30/2025
0.05319 %	pfp Advisory GmbH	156,081	59,500	6/30/2025
0.05212 %	Vanguard Investments Australia Ltd.	152,932	-477	6/30/2025
0.05203 %	BNP Paribas Asset Management UK Limited	152,655	20,345	6/30/2025
0.04828 %	UBS Fund Management (Switzerland) AG	141,665	3,767	7/31/2025
0.04821 %	T. Rowe Price Associates, Inc.	141,443	10,300	6/30/2025
0.04771 %	JP Morgan Asset Management	139,999	1,342	6/30/2025
0.04660 %	Storebrand Kapitalforvaltning AS	136,744	0	6/30/2025
0.04634 %	Zürcher Kantonalbank (Asset Management)	135,970	1,149	7/31/2025
0.04533 %	Lupus alpha Asset Management AG	133,000	-41,000	4/30/2025
0.04484 %	Eurizon Capital S.A.	131,563	-17,245	6/30/2025
0.04139 %	BMO Asset Management Inc.	121,442	0	7/31/2025
0.04042 %	GVC Gaesco Gestión SGIIC S.A.	118,600	7,200	3/31/2025
0.04028 %	MainFirst Asset Management	118,195	0	6/30/2025
0.04002 %	PGGM Vermogensbeheer B.V.	117,434	9,694	3/31/2025
0.03936 %	BWM AG	115,500	0	9/30/2024
0.03936 %	LLB Fund Services AG	115,500	0	6/30/2025
0.03936 %	MFS Investment Management	115,486	22,490	6/30/2025
0.03889 %	SEB Investment Management AB	114,107	-5,723	6/30/2025
0.03775 %	DBX Advisors LLC.	110,759	0	7/31/2025
0.03614 %	Credit Mutuel Asset Management	106,042	0	5/31/2025
0.03569 %	DWS International GmbH	104,729	33,363	6/30/2025
0.03489 %	Fidelity Management & Research Company LLC	102,365	7,726	7/31/2025
0.03396 %	BlackRock Asset Management Canada Limited	99,657	12,359	7/31/2025
0.03358 %	BlackRock Financial Management, Inc.	98,524	-5,301	3/31/2025
0.03328 %	Quoniam Asset Management GmbH	97,634	63,651	3/31/2025
0.03300 %	Los Angeles Capital Management LLC	96,820	58,971	6/30/2025
0.03268 %	Templeton Investment Counsel, L.L.C.	95,876	0	6/30/2025
0.03170 %	Jupiter Asset Management Ltd.	92,998	92,248	6/30/2025
0.03090 %	SEI Investments Canada	90,665	0	3/31/2025
0.03072 %	BlackRock Investment Management, LLC	90,148	3,034	6/30/2025
0.03064 %	BNP Paribas Asset Management Belgium S.A.	89,903	46,323	6/30/2025
0.02849 %	Thrivent Asset Management, LLC	83,597	0	5/31/2025
0.02843 %	ARCA Fondi SGR S.p.A	83,430	23,545	6/30/2025

...

Fresenius Medical Care Executives and Management Board

Ms. Helen Giza

(57)

Fresenius Medical Care Chairman of the Management Board, Chief Executive Officer

Compensation 4.44 M EUR

Mr. Craig Cordola

(54)

Fresenius Medical Care Member of the Management Board, Chief Executive Officer - Care Delivery

Compensation 3.72 M EUR

Dr. Katarzyna Mazur-Hofsaess

(62)

Fresenius Medical Care Member of the Management Board, Chief Executive Officer - Care Enablement

Compensation 3.28 M EUR

Dr. Frank Maddux

(68)

Fresenius Medical Care Member of the Management Board, Global Chief Medical Officer

Compensation 2.76 M EUR

Mr. Martin Fischer

(49)

Fresenius Medical Care Chief Financial Officer, Member of the Management Board

Compensation 2.52 M EUR

Most common questions regarding Fresenius Medical Care

Fresenius Medical Care AG is a leading global provider of dialysis products, services, and solutions for patients with chronic kidney failure. The company's business model revolves around providing high-quality dialysis care to patients in over 120 countries. Fresenius Medical Care AG offers a comprehensive range of dialysis machines, dialyzers, and other related products to ensure efficient and effective treatment. Furthermore, the company operates a network of dialysis clinics, providing personalized care for patients worldwide. With a focus on innovation, research, and development, Fresenius Medical Care AG continuously strives to enhance patient outcomes and improve the overall quality of life for individuals with kidney disease.

Fresenius Medical Care AG is a leading provider of products and services for the dialysis treatment of patients with kidney failure. The company is headquartered in Bad Homburg, Germany, and operates in over 120 countries worldwide. Fresenius Medical Care also operates its own dialysis centers and offers various other medical services. The business model of Fresenius Medical Care includes three business segments: dialysis products, services related to dialysis treatment, and the care of patients with chronic diseases. In the field of dialysis products, Fresenius Medical Care develops and produces a wide range of dialysis equipment and reagents. These products are sold to both their own dialysis centers and other medical facilities worldwide. Thanks to technological innovations in dialysis treatment, medical professionals can offer patients better outcomes and a higher quality of life. In the second business segment, Fresenius Medical Care provides services related to dialysis treatment. The company operates and manages its own dialysis centers and also provides the necessary medical professionals. Additionally, Fresenius Medical Care offers technical support and training for the use of their own dialysis products. These services are an important part of the business model as they ensure both the sales of their own products and the high-quality medical care of patients. A third business segment of Fresenius Medical Care is the care of patients with chronic diseases. Through the use of data analysis and telemedicine technologies, medical professionals from Fresenius Medical Care can actively care for patients - both online and through home visits. The goal is to improve the health of patients and avoid hospital stays. The business model of Fresenius Medical Care is based on preventive health care and support for people with chronic diseases such as kidney failure. By providing high-quality products and services and establishing a comprehensive patient care program, Fresenius Medical Care strengthens its position as a leading provider in dialysis treatment. In recent years, Fresenius Medical Care has also increased its investment in research and development of innovative treatment methods to continuously improve the quality of medical care for patients with chronic diseases. The extensive expertise in this field enables the development of new treatment modalities, including digital solutions, that benefit patients. Overall, Fresenius Medical Care is an innovative company specializing in the provision of products and services for dialysis treatment. By combining technological innovations, a comprehensive patient care program, and a constant focus on the needs of medical professionals in the global healthcare industry, the company relies on a forward-looking, promising business model in a sector of growing importance.

Sector

Health

Industry

gsubind_Health Care Services

Number of shares

293,413,500

Employees

121,403

Revenue growth Ø5 years

1.6 %

EBIT growth Ø5 years

-10.79 %

Net Income growth Ø5 years

-14.31 %

Website freseniusmedicalcare.com

Country

🇩🇪

Currency

EUR

Initial public offering

Oct 2, 1996

ISIN

DE0005785802

Cusip

D2734Z107

Sedol

5129074

Market capitalization

11.9 B EUR

Fresenius Medical Care Directors Dealings

Quality Investing

Details

2 / 10

PEG

2.88

P/E ratio

22.11

Forward P/E ratio 2025

10.25

Forward P/E ratio 2026

9.78

Forward P/E ratio 2027

8.61

Forward P/E ratio 2028

7.25

Forward P/E ratio 2029

7.01

P/S ratio

0.62

Forward P/S ratio

0.6

ROE (Return on Equity)

3.69 %

ROA (Return on Assets)

1.6 %

ROCE (Return on Capital Employed)

4.54 %

ROIC (Return on Invested Capital)

0.55 %

Dividend

1.44 EUR

Dividend yield

3.55 %

Dividend growth Ø5Y

1.45 %

Dividend payments per year

Dividend paid since

35 years

Dividend not reduced since

32 years

Dividend increased since

32 years

Dividend withholding tax

26.38 %

Fresenius Medical Care Peer Group

Fresenius SE & Co KGaA

Euroeyes International Eye Clinic Ltd

Vita 34 AG

Synlab AG

Limes Schlosskliniken AG

Fresenius Medical Care Eulerpool News

Eulerpool News December 3 · Pharma · 3. Dezember 2024

Fresenius Medical Care Stock on Recovery Path After Analyst Praise

Eulerpool News May 7 · Pharma · 7. Mai 2024

FMC Confirms Forecast: Fresenius Investment Stable

Eulerpool News February 20 · Pharma · 20. Februar 2024

Fresenius Medical Care Increases Profit Thanks to Cost Savings

Eulerpool News November 3 · Pharma · 3. November 2023

Fresenius shows more confidence in earnings development

Fresenius Medical Care Earnings Calls

No Earnings Calls available for Fresenius Medical Care

Fresenius Medical Care News

All Fresenius Medical Care News

Fresenius Medical Care Ticker

Stock Exchange	Fresenius Medical Care Ticker
DÜSSELDORF	FME.DU
FRANKFURT	FME.F
HAMBURG	FME.HM
LONDON	0H9X.L
MILAN	FME.MI
MUNICH	FME.MU
PNK	FMCQF
SIX	FMEEUR.SW
VIENNA	FME.VI
XETRA	FME.DE

Fresenius Medical Care FIGI

Fresenius Medical Care Ticker	Fresenius Medical Care FIGI
FME:GR	BBG000DHXQT2
FME:GF	BBG000DHXRP4
FME:GD	BBG000DHXT16
FME:GY	BBG000DHXTF1
FME:GS	BBG000DHXV11
FME:GM	BBG000DHYWY2
FME:GB	BBG000DHYXP0
FME:GI	BBG000DHYYF9
FME:GH	BBG000DHYYR6
FMCQF:US	BBG000LYFMB4
FMCQF:UV	BBG000LYHZ23
FMED:IX	BBG000Q8FK57
FME:EO	BBG000QPJ9D1
FME:XH	BBG000QPJBK8
FME:XC	BBG000QPJC08
FME:XF	BBG000QPJC62
FME:XE	BBG000QPJCS8
FME:XJ	BBG000QPJD33
FME:XL	BBG000QPJDC3
FME:XG	BBG000QPJDP9
FME:XO	BBG000QPJDT5
FME:XS	BBG000QPJGT8
FME:XA	BBG000QPJGY2
FME:E1	BBG000QPJH98
FME:XT	BBG000QPJJG6
FME:XW	BBG000QPJJQ5
FME:EU	BBG000QPJL62
FMEGBX:EU	BBG000QZX2G5
FMEGBP:EO	BBG000QZX2W7
FMEGBP:E1	BBG000QZX890
FMEGBP:XT	BBG000QZX8J9
FMEGBP:XW	BBG000QZX8R0
FMEUSD:EU	BBG000R1W5K8
FMEUSD:EO	BBG000R1W5Z2
FMEUSD:E1	BBG000R1WC69
FMEUSD:XT	BBG000R1WCH7
FMEUSD:XW	BBG000R1WCL2
FMEGBX:EO	BBG000R4JBB4
FMEGBX:XH	BBG000R4JDB0
FMEGBX:XC	BBG000R4JDJ2
FMEGBX:XF	BBG000R4JDP5
FMEGBX:XE	BBG000R4JG32
FMEGBX:XJ	BBG000R4JGC2
FMEGBX:XL	BBG000R4JGK3
FMEGBX:XG	BBG000R4JGS5
FMEGBX:XO	BBG000R4JH21
FMEGBX:XS	BBG000R4JK88
FMEGBX:XA	BBG000R4JKF0
FMEGBX:E1	BBG000R4JKK4
FMEGBX:XT	BBG000R4JKQ8
FMEGBX:XW	BBG000R4JLC1
FMED:TQ	BBG000RH8RT3
FMED:BQ	BBG000RL2F16
FMED:EB	BBG000RL5M72
FMEAUD:EO	BBG000RV4J69
FMEAUD:E1	BBG000RV4RC4
FMEAUD:XT	BBG000RV4RG0
FMEAUD:XW	BBG000RV4RK5
FMEAUD:EU	BBG000RV4SL2
FMECHF:EO	BBG000RV4T76
FMECHF:E1	BBG000RV4ZC6
FMECHF:XT	BBG000RV4ZZ1
FMECHF:XW	BBG000RV5087
FMECHF:EU	BBG000RV50L2
FMENOK:EO	BBG000RV5112
FMENOK:E1	BBG000RV5693
FMENOK:XT	BBG000RV56H4
FMENOK:XW	BBG000RV56N7
FMENOK:EU	BBG000RV57T9
0H9X:LO	BBG000S99PQ6
FME:TH	BBG000TL3DS9
FMED:S1	BBG001MBWWL9
FME:XV	BBG00591D715
FMEGBP:XV	BBG00591MND7
FMEGBX:XV	BBG00591Q5G9
FMEAUD:XV	BBG00591VJ73
FMECHF:XV	BBG00591VJ82
FMENOK:XV	BBG00591VJT9
FMED:QX	BBG005HKZR43
FMED:L3	BBG006T9R5G7
FMED:B3	BBG006TBK5M2
FME:SW	BBG006TLQ072
FME:SE	BBG006TLQ090
FME:BW	BBG006TLQ0F3
FME:QT	BBG0077H52F3
FMEN:MM	BBG007B25W74
FMEN:MF	BBG007B25W83
FMCQFN:B3	BBG007WWWF54
FMCQFN:L3	BBG007WWZR19
FMCQFN:PO	BBG008GZN715
FMED:PO	BBG008GZN760
FMEEUR:SW	BBG008P7FZZ7
FMEEUR:SE	BBG008P7G010
FMECAD:EO	BBG00BMHML11
FMECAD:XH	BBG00BMHML48
FMECAD:XF	BBG00BMHML66
FMECAD:XE	BBG00BMHML84
FMECAD:XJ	BBG00BMHML93
FMECAD:XL	BBG00BMHMLB0
FMECAD:XG	BBG00BMHMLC9
FMECAD:XO	BBG00BMHMLD8
FMECAD:XS	BBG00BMHMLJ2
FMECAD:XA	BBG00BMHMLK0
FMECAD:E1	BBG00BMHMLL9
FMECAD:XT	BBG00BMHMLM8
FMECAD:XW	BBG00BMHMLN7
FMECAD:XU	BBG00BMHMLP5
FMECAD:XV	BBG00BMHMLQ4
FMECAD:EU	BBG00BMHMLS2
1FME:IM	BBG00DB6FL11
1FME:IF	BBG00DB6FL39
FME:GZ	BBG00FGWSX05
FME:AV	BBG00GY18BW6
4FME:TE	BBG00HLJD529
FME:XM	BBG00J9VJ5D4
FME:XX	BBG00JN79W16
FMEGBP:XX	BBG00JN7K9K3
FMEUSD:XX	BBG00JN7L2B7
FMEGBX:XX	BBG00JN7MTF3
FMEAUD:XX	BBG00JN7S541
FMECHF:XX	BBG00JN7S550
FMENOK:XX	BBG00JN7S5Q7
FMECAD:XX	BBG00JN8GCK9
FMEN:MU	BBG00JX0QB80
FMEEUR:T2	BBG00NFNRT90
FMED:QE	BBG00NL2SD75
FMED:T1	BBG00NLK2FM1
FMED:I2	BBG00NQC5810
FMEEUR:WT	BBG00NR9NDL3
FMCQFN:L1	BBG00Y9119R3
FMED:L1	BBG00Y9119X6
FMED:S4	BBG00YJ83KH1
FME:LA	BBG018H7JSM1
FME:LU	BBG018J15W20

All fundamentals about Fresenius Medical Care

Our stock analysis for Fresenius Medical Care Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fresenius Medical Care Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

The Modern Financial Terminal

Trusted by leading companies and financial institutions

Fresenius Medical Care Stock FME.DE

Price

Price

TickerFME.DE

ISINDE0005785802

Fresenius Medical Care stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Fresenius Medical Care Revenue, EBIT, Net Income

Fresenius Medical Care Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Fresenius Medical Care stock margins

Fresenius Medical Care Stock Sales Revenue, EBIT, Earnings per Share

Fresenius Medical Care business model

Fresenius Medical Care SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Fresenius Medical Care Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Fresenius Medical Care historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Fresenius Medical Care shares outstanding

Fresenius Medical Care stock splits

Fresenius Medical Care dividend history and estimates

Fresenius Medical Care dividend payout ratio

The World’s Best Investors Are On Eulerpool

Fresenius Medical Care Earnings Calls

Fresenius Medical Care Earnings Estimates

Eulerpool ESG Scorecard© for the Fresenius Medical Care stock

Eulerpool World ESG Rating (EESG©)

81/ 100

🌱 Environment

👫 Social

🏛️ Governance

Environment

Social

Governance (Corporate Governance)

Fresenius Medical Care shareholders

Fresenius Medical Care Executives and Management Board

Ms. Helen Giza

Mr. Craig Cordola

Dr. Katarzyna Mazur-Hofsaess

Dr. Frank Maddux

Mr. Martin Fischer

Most common questions regarding Fresenius Medical Care

What is the business model of Fresenius Medical Care?

In which industries is Fresenius Medical Care primarily active?

Who are the main competitors of Fresenius Medical Care in the market?

What is the history and background of the company Fresenius Medical Care?

What significant milestones has the company Fresenius Medical Care achieved?

In which countries and regions is Fresenius Medical Care primarily present?

What values and corporate philosophy does Fresenius Medical Care represent?

Ticker
FME.DE

ISIN
DE0005785802